Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2012
11/14/2012CN101903021B Alpha-aminoamide derivatives useful in the treatment of psychiatric disorders
11/14/2012CN101897671B Xylitol micro pill preparations and preparation method thereof
11/14/2012CN101892237B Polynucleotide related to mitochondrial membrane potential decrease and coded polypeptide and application thereof
11/14/2012CN101891736B 1,3,4-thiadiazole (oxadiazole) derivatives based on benzoisoselenothiazolidone structure, and preparation method and application thereof
11/14/2012CN101891674B 4-styryl pyridine compound and preparation method as well as application thereof
11/14/2012CN101879169B Compound preparation for treating relevant vascular diseases and preparation method thereof
11/14/2012CN101874030B Pyrrolidines and piperidines as orexin receptor antagonists
11/14/2012CN101874028B 2-aza-bicyclo[3.3.0]octane derivatives
11/14/2012CN101843592B Preparation method of decitabine freeze-dried powder injection
11/14/2012CN101835748B Amino arylsulfonamide compounds and their use as 5-HT6 ligands field of invention
11/14/2012CN101821235B Pyrrolidin-2 -one derivatives as androgen receptor modulator
11/14/2012CN101820880B Therapeutic agent for inflammatory bowel disease comprising uracil derivative as active ingredient
11/14/2012CN101815513B Ophthalmic formulation containing paracetamol
11/14/2012CN101808654B Compounds extracted from palm oil mill effluent for the treatment of cancer, compositions thereof and methods therewith
11/14/2012CN101801390B Medicinal agent for disease associated with epstein-barr virus, and method for screening of the medicinal agent
11/14/2012CN101795677B Spiro compounds for treatment of inflammatory disorders
11/14/2012CN101785860B Tegafur/layered duplex metal hydroxide nanometer hybrid and preparation method thereof
11/14/2012CN101778846B 1,2-diamido-ethylene derivatives as orexin antagonists
11/14/2012CN101759672B Salvianolic acid B in radix salviae miltiorrhizae
11/14/2012CN101756957B Pharmaceutical composition containing artemisinin, artemisinin derivatives and histon deacetylase (HDAC) inhibitor and application thereof
11/14/2012CN101744786B Prescription of felodipine sustained-release tablets and preparation method
11/14/2012CN101735211B Applications of 2,3-dihydro[1,5] benzothiazepine compounds or salts thereof in preparation of GSK-3beta inhibitor
11/14/2012CN101716162B Aminophylline slow-release capsules and preparation method thereof
11/14/2012CN101716135B Soy isoflavone solid dispersion suppository and preparation method thereof
11/14/2012CN101711858B Medicine for treating cancer
11/14/2012CN101679441B Compounds for the treatment of hepatitis c
11/14/2012CN101626771B Therapeutic agent for meniere's disease
11/14/2012CN101611012B Cycloalkylamine substituted isoquinoline derivatives
11/14/2012CN101578273B Hydroxylated and methoxylated cyclopenta [d] pyrimidines as akt protein kinase inhibitors
11/14/2012CN101547931B Motilde polymorphs
11/14/2012CN101541747B Biphenyl amide lactam derivatives as inhibitors of 11- beta-hydroxysteroid dehydrogenase 1
11/14/2012CN101535268B Tyrosine kinase inhibitors
11/14/2012CN101531642B Method for preparing pinaverium bromide and application thereof
11/14/2012CN101528726B Thiophene derivatives as S1P1/EDG1 receptor agonists
11/14/2012CN101496827B Application of pumpkin protein in preparing medicament for treating chronic myeloid leukemia
11/14/2012CN101495493B Novel aminoglycoside antibiotic
11/14/2012CN101479276B Pharmaceutical compounds
11/14/2012CN101475563B 3-amino-4-indole-N-methyl maleimide compound, preparation and use thereof
11/14/2012CN101474148B Oral liquid sustained-release preparation containing codeine and chlorphenamine and preparation method thereof
11/14/2012CN101472571B Treating obesity with muscarinic receptor m1 antagonists
11/14/2012CN101466381B Stereoselective reduction of a morphinone
11/14/2012CN101460148B Solid dispersion of poorly soluble drugs in graft copolymers
11/14/2012CN101450938B 7-(4-oximido-3-amido-3-alkyl-1-piperidine)quinoline carboxylic acid derivates and preparation method thereof
11/14/2012CN101442997B Use of rasagiline for the treatment of restless legs syndrome
11/14/2012CN101421276B Dimers of artemisinin derivatives, preparation thereof and therapeutic use thereof
11/14/2012CN101361853B Medicine composition for preventing the birth defect and improving the memory
11/14/2012CN101346371B 4- (3-aminopyrazole) pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancer
11/14/2012CN101341138B Cyclic anilino-pyridinotriazines as GSK-3 inhibitors
11/14/2012CN101321730B Cyclopropyl amines as modulators of the histamine H3 receptor
11/14/2012CN101312940B Glucagon receptor antagonists, preparation and therapeutic uses
11/14/2012CN101309909B 2-phenylethylamino derivatives as calcium and/or sodium channel modulators
11/14/2012CN101306040B Medicine composition for preventing the birth defect and improving the memory
11/14/2012CN101302170B Optical activity (+) or (-)-gossypol derivates, preparation and use thereof
11/14/2012CN101288643B Gel composition containing tacrolimu and its preparation method and medicinal application
11/14/2012CN101287475B Therapeutic compositions comprising hyaluronan and therapeutic antibodies as well as methods of treatment
11/14/2012CN101278896B Chitosan nano silver gel agent and uses thereof
11/14/2012CN101269014B Orally disintegrating tablet of risperidone and preparation method thereof
11/14/2012CN101255184B Hepatitis B resistant compound, medicament composition and use in medicament preparation
11/14/2012CN101243066B Delta and epsilon crystal forms of imatinib mesylate
11/14/2012CN101203504B Antimicrobial agents
11/14/2012CN101175757B Synthesis and purification of pteroic acid and conjugates thereof
11/14/2012CN101172957B Novel compound, synthetic method thereof and therapeutic usage
11/14/2012CN101128469B Protease inhibitor precursor synthesis
11/14/2012CN101088499B Dry asarol emulsion and its prepn and application
11/14/2012CN101087609B Factor Xa compounds
11/14/2012CN101068801B Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
11/14/2012CN101065370B 5-hydroxy-benzothiazole derivatives having beta-2-adrenoreceptor agonist activity
11/14/2012CN101048064B Antiseptic compositions and methods of use
11/14/2012CN101043878B Aliphatic amine polymer salts for tableting
11/13/2012USRE43802 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
11/13/2012US8309788 Protease inhibitors in absorbent articles
11/13/2012US8309767 2-aminobenzoyl derivatives
11/13/2012US8309766 Phenyl-containing n-acyl amine and aminoacid derivatives, methods for the production thereof, a pharmaceutical composition and the use thereof
11/13/2012US8309745 Epigallocatechin dimers or trimers having lipase inhibitory activity and/or antioxidant activity
11/13/2012US8309735 Heterocyclic compounds for the inhibition of integrins and use thereof
11/13/2012US8309730 Nonsteroidal compounds useful as modulators of glucocorticoid receptor AP-1 and/or NF-kappab acitivity and use thereof
11/13/2012US8309729 Therapeutically useful substituted hydropyrido [3,2,1-ij] quinoline compounds
11/13/2012US8309709 Method of preparing a separation matrix
11/13/2012US8309679 Polyquaternium-1 synthesis methods
11/13/2012US8309613 Solid pharmaceutical dosage form
11/13/2012US8309612 Method for treating age-related macular degeneration
11/13/2012US8309611 Methods and compositions for treating lung cancer
11/13/2012US8309610 Crystalline forms of (1RS,3RS,6RS)-6-dimethylaminomethyl-1-(3-methoxyphenyl)cyclohexane-1,3-diol hydrochloride
11/13/2012US8309609 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands
11/13/2012US8309608 Endothelial nitric oxide synthase (eNOS) for treating stem and progenitor cells; for treating cardiomyopathy, congestive heart failure
11/13/2012US8309607 Rapid release irbesartan-containing pharmaceutical composition
11/13/2012US8309606 Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection
11/13/2012US8309605 Enhanced bimatoprost ophthalmic solution
11/13/2012US8309604 Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses
11/13/2012US8309603 SARMs and method of use thereof
11/13/2012US8309602 Multi-substituted diarylanilines as non-nucleoside HIV reverse transcriptase inhibitors, and preparation and use thereof
11/13/2012US8309601 Forms of CDDO methyl ester
11/13/2012US8309600 GPR120 receptor agonists and uses thereof
11/13/2012US8309599 Synthesis of FR901464 and analogs with antitumor activity
11/13/2012US8309598 Cooling compounds
11/13/2012US8309597 1,1′-diadamantyl carboxylic acids, medicaments containing such compounds and their use
11/13/2012US8309596 Kallikrein 7 modulators
11/13/2012US8309595 Hydrazone modulators of cannabinoid receptors
11/13/2012US8309594 Purification of progesterone receptor modulators
11/13/2012US8309593 2-acylaminopropoanol-type glucosylceramide synthase inhibitors
1 ... 961 962 963 964 965 966 967 968 969 970 971 972 973 974 975 976 977 978 979 980 981 ... 7860